GENERATION BIO CO (GBIO) Stock Income Statement
NASDAQ:GBIO - Nasdaq - US37148K1007 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.89M | 5.90M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 99.08M | 144.47M | 135.38M | 119.10M | 81.11M | |||
| Research and Development | 61.30M | 93.62M | 90.92M | 85.25M | 58.53M | |||
| Selling, General, and Administrative Expenses | 37.78M | 50.85M | 44.46M | 33.85M | 22.58M | |||
| Operating Income | -79.19M | -138.56M | -135.38M | -119.10M | -81.11M | |||
| Interest Income/Expense | 10.72M | 11.95M | 4.54M | -50.00K | 590.00K | |||
| Non Recurring Items | -63.20M | N/A | -5.80M | N/A | N/A | |||
| Income Before Taxes | -131.67M | -126.61M | -136.64M | -119.15M | -80.52M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -131.67M | -126.61M | -136.64M | -119.15M | -80.52M | |||
| EBITDA | -74.26M | -133.30M | -130.25M | -114.57M | -77.68M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.98 | -1.96 | -2.35 | -2.12 | -1.74 | |||
| Non GAAP EPS | -1.98 | -1.96 | -2.35 | -2.11 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -661.91% | -2144.51% | N/A | N/A | N/A | |||
| Operating Profit Margin | -398.11% | -2346.93% | N/A | N/A | N/A | |||
All data in USD